Home LiteratureArticle Details
PMID: 8612581 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect.

The EMBO journal ·Vol. 15 ·No. 7 ·1996-04-01 ·Pages 1572-82

Resnati M, Guttinger M, Valcamonica S, Sidenius N, Blasi F, Fazioli F

Abstract

Physiological concentrations of urokinase plasminogen activator (uPA) stimulated a chemotactic response in human monocytic THP-1 through binding to the urokinase receptor (uPAR). The effect did not require the protease moiety of uPA, as stimulation was achieved also with the N-terminal fragment (ATF), while the 33 kDa low molecular weight uPA was ineffective. Co-immunoprecipitation experiments showed association of uPAR with intracellular kinase(s), as demonstrated by in vitro kinase assays. Use of specific antibodies identified p56/p59hck as a kinase associated with uPAR in THP-1 cell extracts. Upon addition of ATF, p56/p59hck activity was stimulated within 2 min and returned to normal after 30 min. Since uPAR lacks an intracellular domain capable of interacting with intracellular kinase, activation of p56/p59hck must require a transmembrane adaptor. Evidence for this was strongly supported by the finding that a soluble form of uPAR (suPAR) was capable of inducing chemotaxis not only in THP-1 cells but also in cells lacking endogenous uPAR (IC50, 5 pM). However, activity of suPAR require chymotrypsin cleavage between the N-terminal domain D1 and D2 + D3. Chymotrypsin-cleaved suPAR also induced activation of p56/p59hck in THP-1 cells, with a time course comparable with ATF. Our data show that uPA-induced signal transduction takes place via uPAR, involves activation of intracellular tyrosine kinase(s) and requires an as yet undefined adaptor capable of connecting the extracellular ligand binding uPAR to intracellular transducer(s).

MeSH Terms
Animals Antibodies, Blocking/pharmacology Antibodies, Monoclonal/pharmacology Cell Line Chemotaxis, Leukocyte/drug effects,physiology Cricetinae Endopeptidases/metabolism Enzyme Activation Humans In Vitro Techniques Mice Monocytes/physiology Peptide Fragments/chemistry,metabolism,pharmacology Protein-Tyrosine Kinases/metabolism Proto-Oncogene Proteins/metabolism Proto-Oncogene Proteins c-hck Receptor Aggregation Receptors, Cell Surface/metabolism Receptors, Urokinase Plasminogen Activator Signal Transduction Urokinase-Type Plasminogen Activator/chemistry,metabolism,pharmacology
Chemicals
Antibodies, Blocking Antibodies, Monoclonal PLAUR protein, human Peptide Fragments Plaur protein, mouse Proto-Oncogene Proteins Receptors, Cell Surface Receptors, Urokinase Plasminogen Activator Protein-Tyrosine Kinases HCK protein, human Hck protein, mouse Proto-Oncogene Proteins c-hck Endopeptidases Urokinase-Type Plasminogen Activator
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Resnati M
Department of Biology and Biotechnology, San Raffaele Scientific Institute, Milano, Italy.
Guttinger M
Valcamonica S
Sidenius N
Blasi F
Fazioli F
References (49)
49 references, click to expand
  1. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.
    Cell. 1991 Mar 22;64(6):1057-68 PMID: 1672265
  2. Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor.
    Proc Natl Acad Sci U S A. 1989 Jul;86(13):4828-32 PMID: 2544876
  3. The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator.
    J Biol Chem. 1991 Apr 25;266(12):7842-7 PMID: 1850423
  4. A soluble, ligand binding mutant of the human urokinase plasminogen activator receptor.
    J Biol Chem. 1991 May 15;266(14):8655-8 PMID: 1851152
  5. Single chain urokinase. Augmentation of enzymatic activity upon binding to monocytes.
    J Biol Chem. 1991 Aug 5;266(22):14580-4 PMID: 1907280
  6. Cell-induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2-terminal domain of the urokinase receptor.
    FEBS Lett. 1991 Aug 19;288(1-2):233-6 PMID: 1715292
  7. Use and specificity of genistein as inhibitor of protein-tyrosine kinases.
    Methods Enzymol. 1991;201:362-70 PMID: 1658553
  8. Use and selectivity of herbimycin A as inhibitor of protein-tyrosine kinases.
    Methods Enzymol. 1991;201:370-9 PMID: 1658554
  9. GPI-anchored cell-surface molecules complexed to protein tyrosine kinases.
    Science. 1991 Nov 15;254(5034):1016-9 PMID: 1719635
  10. Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradation.
    Cell Regul. 1991 Oct;2(10):793-803 PMID: 1666303
  11. Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor.
    J Biol Chem. 1992 May 5;267(13):9129-33 PMID: 1315748
  12. cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator.
    J Immunol. 1992 Jun 1;148(11):3636-42 PMID: 1316922
  13. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis.
    EMBO J. 1990 Feb;9(2):467-74 PMID: 1689240
  14. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2.
    J Immunol. 1990 Mar 1;144(5):1873-9 PMID: 2307845
  15. Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors.
    J Biol Chem. 1990 Jun 15;265(17):9904-8 PMID: 2161846
  16. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes.
    J Cell Biol. 1990 Aug;111(2):783-92 PMID: 2166055
  17. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol.
    J Biol Chem. 1991 Jan 25;266(3):1926-33 PMID: 1846368
  18. The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation.
    Experientia. 1991 Jan 15;47(1):22-31 PMID: 1999239
  19. Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes.
    J Biol Chem. 1992 Jul 25;267(21):14543-6 PMID: 1378833
  20. Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain.
    J Biol Chem. 1992 Sep 5;267(25):18224-9 PMID: 1381366
  21. LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation.
    Cell. 1992 Oct 30;71(3):411-21 PMID: 1423604
  22. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor.
    EMBO J. 1992 Dec;11(13):4825-33 PMID: 1334458
  23. Biology and biochemistry of proteinases in tumor invasion.
    Physiol Rev. 1993 Jan;73(1):161-95 PMID: 8419965
  24. Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells.
    Biochem Biophys Res Commun. 1993 Jan 29;190(2):347-52 PMID: 8381273
  25. Interaction of urokinase-type plasminogenactivator (u-PA) with its cellular receptor (u-PAR) induces phosphorylation on tyrosine of a 38 kDa protein.
    FEBS Lett. 1993 May 3;322(1):37-40 PMID: 8387028
  26. Distribution and lateral mobility of the urokinase-receptor complex at the cell surface.
    J Histochem Cytochem. 1993 Sep;41(9):1291-301 PMID: 8394852
  27. Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy?
    Trends Pharmacol Sci. 1994 Jan;15(1):25-9 PMID: 8140655
  28. The urokinase receptor is required for human monocyte chemotaxis in vitro.
    J Clin Invest. 1994 Apr;93(4):1380-7 PMID: 8163642
  29. Protease nexin-1-urokinase complexes are internalized and degraded through a mechanism that requires both urokinase receptor and alpha 2-macroglobulin receptor.
    J Biol Chem. 1994 Jul 8;269(27):17886-92 PMID: 8027043
  30. Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells.
    J Cell Biol. 1994 Jul;126(1):259-70 PMID: 7517943
  31. Ligand interaction between urokinase-type plasminogen activator and its receptor probed with 8-anilino-1-naphthalenesulfonate. Evidence for a hydrophobic binding site exposed only on the intact receptor.
    Biochemistry. 1994 Aug 2;33(30):8991-7 PMID: 8043585
  32. A cleaved form of the receptor for urokinase-type plasminogen activator in invasive transplanted human and murine tumors.
    Int J Cancer. 1994 Sep 15;58(6):877-81 PMID: 7927882
  33. Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction.
    J Biol Chem. 1995 Jan 13;270(2):603-11 PMID: 7822285
  34. Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes.
    J Exp Med. 1995 Apr 1;181(4):1381-90 PMID: 7535337
  35. The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility.
    J Biol Chem. 1995 Jul 14;270(28):16886-94 PMID: 7622505
  36. Biosynthesis and apical localization of the urokinase receptor in polarized MDCK epithelial cells.
    FEBS Lett. 1995 Aug 7;369(2-3):207-11 PMID: 7649259
  37. Phosphorylation sites in enolase and lactate dehydrogenase utilized by tyrosine protein kinases in vivo and in vitro.
    J Biol Chem. 1984 Jun 25;259(12):7835-41 PMID: 6330085
  38. A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.
    J Cell Biol. 1985 Jan;100(1):86-92 PMID: 3880760
  39. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes.
    Proc Natl Acad Sci U S A. 1985 Aug;82(15):4939-43 PMID: 2991901
  40. Purification of the catalytically active phosphorylated form of insulin receptor kinase by affinity chromatography with O-phosphotyrosyl-binding antibodies.
    Arch Biochem Biophys. 1985 Oct;242(1):176-86 PMID: 2413806
  41. Autocrine saturation of pro-urokinase receptors on human A431 cells.
    Cell. 1986 Jun 6;45(5):675-84 PMID: 3011276
  42. The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases.
    J Biol Chem. 1987 Apr 5;262(10):4437-40 PMID: 3031025
  43. Limited cleavage of cellular fibronectin by plasminogen activator purified from transformed cells.
    Proc Natl Acad Sci U S A. 1987 May;84(9):2776-80 PMID: 3033662
  44. Human urokinase-type plasminogen activator stimulates chemotaxis of human neutrophils.
    Biochem Biophys Res Commun. 1987 Sep 30;147(3):1176-81 PMID: 3117059
  45. A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification.
    J Biol Chem. 1988 Feb 15;263(5):2358-63 PMID: 2828365
  46. Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells.
    Exp Cell Res. 1988 Dec;179(2):385-95 PMID: 2847935
  47. Characterization of the cellular binding site for the urokinase-type plasminogen activator.
    J Biol Chem. 1989 Jan 15;264(2):1180-9 PMID: 2536017
  48. Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes.
    J Biol Chem. 1989 Feb 5;264(4):2185-8 PMID: 2521625
  49. Phosphatidylinositol membrane anchors and T-cell activation.
    Immunol Today. 1991 Jan;12(1):35-41 PMID: 1826601
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
1996-04-01
Pages
1572-82
Language
English
Region
England
NLM ID
8208664
PMCID
PMC450067
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com